Intech Biopharm Stock

Intech Biopharm Debt

The Debt of Intech Biopharm (6461.TWO) as of Aug 9, 2026 is 994.90 M TWD. In the previous year, Debt was 1.08 B TWD — a change of -7.69% (lower).

Debt

994.90 MTWD

YoY

-7.69%

Last updated:

In 2026, Intech Biopharm's total debt was 994.90 M TWD, a -7.69% change from the 1.08 B TWD total debt recorded in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Intech Biopharm Stock analysis

What does Intech Biopharm do? Intech Biopharm is one of the most popular companies on Eulerpool.

Debt Details

Understanding Intech Biopharm's Debt Structure

Intech Biopharm's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Intech Biopharm's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Intech Biopharm’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Intech Biopharm’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Intech Biopharm stock

Debt of Intech Biopharm is 994.90 M TWD in 2026.

Debt of Intech Biopharm changed from 1.08 B TWD to 994.90 M TWD, representing a -7.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Intech Biopharm since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Intech Biopharm historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Intech Biopharm

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Intech Biopharm